Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery after Coronary Stent Implantation: A Real-World Bridging Protocol Experience

Antiplatelet Therapy with Cangrelor in Patients Undergoing Surgery after Coronary Stent Implantation: A Real-World Bridging Protocol Experience

Objective The aim of the study is to describe the real-world use of the P2Y12 inhibitor cangrelor as a bridging strategy in patients at high thrombotic risk after percutaneous coronary intervention (PCI) and referred to surgery requiring perioperative withdrawal of dual antiplatelet therapy (DAPT)....

Full description

Bibliographic Details
Main Authors: Roberta Rossini, Giulia Masiero, Claudia Fruttero, Enrico Passamonti, Elba Calvaruso, Moreno Cecconi, Cesare Carlucci, Marco Mojoli, Parodi Guido, Giuseppe Talanas, Simona Pierini, Paolo Canova, Nicoletta De Cesare, Stefania Luceri, Nicoletta Barzaghi, Giulio Melloni, Giorgio Baralis, Alessandro Locatelli, Giuseppe Musumeci, Dominick J. Angiolillo
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2020-10-01
Series:TH Open
Subjects:
antiplatelet therapy
stent
surgery
bridging
cangrelor
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0040-1721504

Similar Items

Similar Items